US whooping cough cases rising, especially in teens, CDC says
Whooping cough cases are climbing at the fastest pace in years as students across America return to school, U.S. health officials reported Thursday.
15 hours ago
0
0
Improvement seen in vaccine completion among military children
Among military children, there has been an improvement in vaccine completion and timeliness, but the risk for noncompletion is higher among children born to younger parents and those with a well-child care location change, ...
19 hours ago
0
0
Searching for a vaccine against an ancient scourge: Syphilis genetics study points to a potential target
Syphilis cases have surged worldwide, leaving public health officials scrounging for ways to stop the spread. Now, a large, collaborative study of syphilis genetics from four continents has found hints of a possible target ...
Sep 19, 2024
0
5
Vaccine experts report positive results on Phase 1 trial of personalized vaccine for lymphoplasmacytic lymphoma
A team of researchers from City of Hope and The University of Texas M.D. Anderson Cancer Center has reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic ...
Sep 19, 2024
0
5
Mild initial clinical course seen for COVID-19 vaccine-linked myocarditis
COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October issue of eClinicalMedicine.
Sep 19, 2024
0
0
Mpox vaccines administered in Rwanda, first in Africa
Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in Rwanda, the African Union's disease control center said Thursday.
Sep 19, 2024
0
0
DR Congo mpox vaccination campagin to begin October 2
The vaccination campaign against mpox in the Democratic Republic of Congo is to begin on October 2, the public health institute said Thursday, as the country registered more than 24,000 cases of the virus.
Sep 19, 2024
0
0
World better positioned against mpox than for COVID: vaccine alliance
Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic raging in Africa, according to the Gavi vaccine alliance.
Sep 19, 2024
0
0
Vaccine alliance secures deal for 500,000 mpox jabs for Africa
The Gavi vaccine alliance announced Wednesday a deal with Danish drugmaker Bavarian Nordic to secure 500,000 jabs against mpox for use in African countries facing an epidemic of the virus.
Sep 18, 2024
0
0
Critical immune factor for host defense against MRSA offers potential explanation for unsuccessful vaccine strategies
Staphylococcus aureus, mostly known from its antibiotic-resistant variant methicillin-resistant Staphylococcus aureus (MRSA), is among the leading causes of both community- and hospital-acquired infections. According to the ...
Sep 17, 2024
0
11
Expert advice on preparing for the fall COVID, flu season
People should prepare for the fall cold and flu season by getting the updated influenza and COVID-19 vaccinations, an infectious diseases expert says.
Sep 16, 2024
0
1
This city is hailed as a vaccination success. Can it be sustained?
On his first day of school at Newcomer Academy, Maikel Tejeda was whisked to the school library. The 7th grader didn't know why.
Sep 16, 2024
0
0
WHO grants first mpox vaccine approval to ramp up response to disease in Africa
The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important step toward fighting the disease in Africa.
Sep 13, 2024
0
0
Promising Lassa fever vaccine is headed to phase I clinical trial
Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Geneva Foundation, have ...
Sep 12, 2024
0
28
National survey shows hesitancy about vaccines this fall, with 37% of respondents believing they don't need vaccination
With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall. The new data comes just as this ...
Sep 12, 2024
0
0
COVID-19, flu and RSV shots: Q&A with a pharmacist
Vaccinations have become a traditional part of flu season with the influenza vaccine revised most years to protect from new strains of the illness.
Sep 12, 2024
0
1
Danish mpox vaccine maker to supply additional 2 mn doses in 2024
Danish drugmaker Bavarian Nordic, on Thursday pledged to supply a further two million doses of its mpox vaccine by the end of the year.
Sep 12, 2024
0
0
A new type of RNA could enhance vaccines and cancer treatments
It all started in the lab. Two Boston University doctoral students, Joshua McGee and Jack Kirsch, were creating and testing different types of RNA—strands of ribonucleic acid, built from chains of chemical compounds called ...
Sep 11, 2024
0
19
One dose of smallpox vaccine found to be moderately effective in preventing mpox infection
One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a study published by The BMJ .
Sep 11, 2024
0
0
Q&A: Is now the time for a new COVID-19 shot?
The COVID-19 summer surge was a surprise, but are we safe now that the numbers are trending downward?
Sep 11, 2024
0
0
New COVID vaccines may be coming to Australia—here's what to know about the JN.1 shots
COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it's estimated COVID shots have saved more than 1.4 million lives in the World Health Organization's (WHO) European region alone ...
Sep 10, 2024
0
0
DR Congo gets 50,000 mpox vaccine delivery from US
Democratic Republic of Congo received on Tuesday 50,000 more vaccine doses from the United States to fight the country's mpox epidemic, adding to some 200,000 donated by the European Union.
Sep 10, 2024
0
0
Cross-disciplinary research makes strides in hepatitis C vaccine development
Around 58 million people suffer from chronic inflammation caused by the hepatitis C virus, and 300,000 people die from the disease every year.
Sep 9, 2024
0
25